Real-World Treatment Pattern and Clinical Outcome With Influential Factors of HR+/HER2-aBC 1L Patients in China
Clinical trial NCT07476170 · RECRUITING
Trial details
- NCT number
- NCT07476170
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-03-20
- Primary completion
- 2027-04-01
- Enrollment
- 14000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.